A phase II trial of single-agent vinflunine as second-line treatment for advanced non-small cell lung cancer (An International Oncology Network Study, #I-05–009)M. Joppert, Cheryl Jones, Mark Knapp et al.|Journal of Clinical Oncology|2008Cited by 3